DCF — PAM HEALTH REHAB HOSP OF SUGAR LAND
Enterprise Value: $12.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$12.5M
Enterprise Value
$3.2M
PV of Cash Flows
$9.3M
PV of Terminal Value
$15.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $20.1M | $1.7M | 9.0% | $0.6M | $0.5M |
| Year 2 | $20.8M | $2.0M | 10.0% | $0.7M | $0.6M |
| Year 3 | $21.4M | $2.2M | 11.0% | $0.9M | $0.7M |
| Year 4 | $22.0M | $2.4M | 11.0% | $1.0M | $0.7M |
| Year 5 | $22.7M | $2.6M | 11.0% | $1.1M | $0.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $12.5M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$19.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000001840250134
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5